Temozolomide in non-small-cell lung cancer: Preliminary results of a phase II trial in previously treated patients

Clinical Lung Cancer

Volumn 3, Issue 4, 2002, Pages 254-258

  Adonizio, Christian S ^a   Babb, James S ^a   Maiale, Christine ^a   Huang, Chao ^a   Donahue, Judy ^a   Millenson, Michael M ^a   Hosford, Martha ^b   Somer, Robert ^a   Treat, Joseph ^a   Sherman, Eric ^a   Langer, Corey J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b Southern Chester County Medical Center   (United States)

Author keywords

Alkylating agents; Blood brain barrier; Daily schedule; Oral chemotherapy; Salvage therapy

Indexed keywords

CISPLATIN; CORTICOSTEROID; COTRIMOXAZOLE; IRINOTECAN; PLATINUM; TAXANE DERIVATIVE; TEMOZOLOMIDE; TRIAZENE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; METASTASIS; NAUSEA AND VOMITING; NEUTROPENIA; PATIENT MONITORING; PHASE 2 CLINICAL TRIAL; RADIOSENSITIZATION; SALVAGE THERAPY; TASK PERFORMANCE; THROMBOCYTE; THROMBOCYTOPENIA;

EID: 0036305536     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2002.n.009     Document Type: Article

References (27)

1. Cancer statistics, 2000
2. Cisplatin/etoposide vs paclitaxel/cisplatin/G-CSF vs paclitaxel/cisplatin in non-small-cell lung cancer
3. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study
4. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
5. Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: A phase II trial
6. Phase I/II trial of combination carboplatin and taxol in non-small cell lung cancer
7. Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer
8. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial
9. A new international staging system for lung cancer
10. Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
11. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens
12. Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours
13. Temozolomide uptake in human astrocytomas demonstrated in vivo
14. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma
15. Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
16. Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine
17. Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide
18. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
19. Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma
20. Temozolomide reduces the metastatic potential of Lewis lung carcinoma (3LL) in mice: Role of alpha-6 integrin phosphorylation
21. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies
22. Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
23. Surgical approach to lung cancer with solitary cerebral metastasis: Twenty-five years’ experience
24. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy
25. Prolonged survival in pathologic stage IIIB non-small cell lung cancer (NSCLC) with concurrent chemoradiotherapy followed by consolidation docetaxel: A phase II study (S9504) of the Southwest Oncology Group (SWOG)
26. Rationale for surgical treatment of brain metastasis in non-small cell lung cancer